was successfully added to your cart.

Your SEO optimized title page contents
Steve Goldner Cannabis Consulting

Quantum 9 Adds Formulator of Methadone Steve Goldner to Cannabis Consulting Team

Chicago-based cannabis consulting firm Quantum 9, Inc. adds Steve Goldner to their elite team of cannabis consultants. Steve Goldner started his amazing career as a Supervisor Forensic Toxicologist at the Office of the Chief Medical Examiner, New York City. While in this position Steve and his team developed the first commercial laboratory chromatography tests for drugs. This incredible development helped launch the drug screening industry in the 1970s.  Steve along with his mentor John Broich from Brookhaven Labs, in Upton New York, then went on to formulate the drug called “methadone” including getting it approved by the FDA.  Steve and John also developed lab procedures to detect LSD, cannabis, and other drugs in a person’s body.  Soon after they founded Mifflin Parma and Spectrum Labs to launch these products and businesses while improving millions of lives that need it most.


Steve Goldner Cannabis Consultant

Steve went on to obtain his law degree at Quinnipiac University Law School. He practiced law in the great state of Connecticut and specialized in gaining FDA approval for new medical technologies, foods, drugs and medical devices. Steve also has served as an FDA Expert Consultant to the National Institutes of Health. Steve’s main focus is in advising testing labs, food, and drug companies on FDA, State, and International compliance. Steve is a member of National Cannabis Industry Association and Chairman of the FOCUS Cannabis Standards Committee for Pharmacology and Laboratory Testing.

Steve currently owns and operates, Regulatory Affairs Associates; the firm has successfully obtained FDA approval for over 240 products.

Quantum 9, Inc. is the premier marijuana consulting firm in North America, their projects have spanned six countries including the United States, Canada, France, Holland, Germany and Puerto Rico. The firm has successfully guided 21 out of 23 applicants through the permit acquisition process internationally with an outstanding 91% success rate.

About Michael Mayes

As Chief Executive Officer for Quantum 9, Inc., Michael has assisted in funding some of the largest commercial cannabis projects in the world. Michael has been a cannabis investor since 2009 in Colorado’s first legal for-profit cannabis market. As the co-founder and CEO of Quantum 9, Inc., Michael has spent years designing technology and collaborating with countless consultants on the forefront of the cannabis industry. Collaborating with the brightest minds and contributing to world-class organizations has been an incredibly enlightening and rewarding experience for him. Also, he has amassed a comprehensive and award-winning team engaged globally for public policy best practices through the prioritization of environmental sustainability and patient care. Michael is a member of the International Cannabinoid Research Society (ICRS), contributor to Marijuana Business Daily, quoted in the Chicago Tribune, Tampa Tribune, Yahoo Finance, Tampa Tribune, Sativa Magazine, CBC and the Daily Herald. His media appearances include several CBS and WGN appearances and international presence on BNN Commodities in Canada. On the public policy front, Michael and his team were instrumental in their work of drafting the Kentucky Medical Marijuana Bill for Senator Perry Clark. Most recently, Michael taught a class for the International Pharmaceutical Academy in Toronto, Canada. He spoke on Cannabis Pharmacology, and the effects cannabis has on the endocannabinoid system.

One Comment

Leave a Reply